<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02414906</url>
  </required_header>
  <id_info>
    <org_study_id>BarretosCH-UTI 1</org_study_id>
    <nct_id>NCT02414906</nct_id>
  </id_info>
  <brief_title>Goal Directed Therapy for Acute Kidney Injury in Critical Ill Patients</brief_title>
  <acronym>GDT-AKIN</acronym>
  <official_title>Goal Directed Therapy in the Early Phase of Acute Kidney Injury in Critical Ill Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Barretos Cancer Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hospital de Base</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital do Servidor Publico Estadual</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Sao Paulo</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Barretos Cancer Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Acute kidney injury (AKI) is a frequent complication in critically ill patients admitted to
      intensive care unit (ICU) and it is associated with increased morbimortality.

      There is evidence that perioperative hemodynamic optimization decreases the incidence of AKI
      in the post operative phase in high-risk patients. We aimed to evaluate if the use of a
      goal-directed therapy to increase oxygen delivery in the early phase of acute kidney injury
      can decrease the prevalence of patients with acute renal failure.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Randomized, controlled, multicenter study.The intervention group was monitored with Flo
      Trac/Vigileo and optimized with fluid challenges, dobutamine and blood transfusion, if
      necessary, to maintain a IDO² ≥600ml/min/m² during 8h. The control group was treated
      according to the discretion of the attending physician.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2010</start_date>
  <completion_date type="Actual">December 2014</completion_date>
  <primary_completion_date type="Actual">February 2014</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>acute kidney injury</measure>
    <time_frame>2 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>death</measure>
    <time_frame>2 months</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>lenght of stay</measure>
    <time_frame>2 months</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">99</enrollment>
  <condition>Acute Kidney Injury</condition>
  <arm_group>
    <arm_group_label>Intervention group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Goal-directed therapy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Control group</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Goal-directed therapy</intervention_name>
    <description>Goal-directed therapy with fluids and dobutamine</description>
    <arm_group_label>Intervention group</arm_group_label>
    <other_name>Protocol of ressuscitation</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients admitted in the Intensive Care Unit with Acute Kidney Injury (AKI) classified
             as AKIN 1 (increase in serum creatinine ≥0.3 mg/dL and/or urine output less than 0.5
             ml/kg/h over 6 hours) for less than 12 hours.

        Exclusion Criteria:

          -  ICU length of stay &gt;10 days, nefrectomy, chronic kidney disease undergoing
             hemodialysis, baseline creatinine ≥4 mg/dL, life expectance ≤ than 1 month, pregnancy,
             severe arrhythmia, severe heart failure (≤ III, NYHA), acute myocardial infarction
             (AMI)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>March 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 8, 2015</study_first_submitted>
  <study_first_submitted_qc>April 8, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 13, 2015</study_first_posted>
  <last_update_submitted>April 8, 2015</last_update_submitted>
  <last_update_submitted_qc>April 8, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 13, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Barretos Cancer Hospital</investigator_affiliation>
    <investigator_full_name>Cristina Prata Amendola</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Goal Directed Therapy</keyword>
  <keyword>Acute Kidney Injury</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wounds and Injuries</mesh_term>
    <mesh_term>Acute Kidney Injury</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

